Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. April 2026 07:30 ET | Quelle: Biogen Inc.

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one ownerAdvancing felzartamab – a CD38-directed...
20. April 2026 06:44 ET | Quelle: Research and Markets

Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of...
20. April 2026 03:17 ET | Quelle: Mordor Intelligence

Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence

Hyderabad, India, April 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the urology devices market size is projected to increase from USD 39.65 billion in 2025 to USD 42.32 billion in...
18. April 2026 06:00 ET | Quelle: Sanofi Winthrop Industrie

Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe

ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe Première étude comparative de phase 4, randomisée, en...
18. April 2026 06:00 ET | Quelle: Sanofi Winthrop Industrie

Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study powered to directly compare the...
17. April 2026 13:20 ET | Quelle: Spherix Global Insights

Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity

Exton, PA, April 17, 2026 (GLOBE NEWSWIRE) -- New data from Spherix Global Insights’ Launch Dynamix™ service indicate that rebalancing agents are continuing to establish a foothold in hemophilia...
17. April 2026 12:00 ET | Quelle: Research and Markets

China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi

Dublin, April 17, 2026 (GLOBE NEWSWIRE) -- The "China Diabetes Devices Market Forecast Report by Types, Distribution Channel, Cities and Company Analysis 2026-2034" has been added to ...
16. April 2026 13:00 ET | Quelle: DelveInsight Business Research LLP

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

New York, USA, April 16, 2026 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight The...
16. April 2026 11:24 ET | Quelle: Research and Markets

Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Thyroid Eye Disease Treatment Market (2026 Edition)" report has been added to ResearchAndMarkets.com's offering.This report provides a complete...
16. April 2026 08:45 ET | Quelle: International Myeloma Foundation

Blood Cancer Patients and Their Supporters Cycle Across Iceland to Raise Funds and Awareness for Multiple Myeloma and the International Myeloma Foundation’s Research

STUDIO CITY, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announces its 3rd annual Iceland Cycling Expedition, taking place August 18-24, 2026, where...

Vorherige Seite

Nächste Seite